Federal Register of Legislation - Australian Government

Primary content

PB 62 of 2021 Determinations/Health as made
This instrument amends the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 104 of 2019) to insert listed pharmaceutical items which must be supplied as complete packs only.
Administered by: Health
Registered 30 Jun 2021
Tabling HistoryDate
Tabled HR03-Aug-2021
Tabled Senate03-Aug-2021
Date of repeal 19 Oct 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

PB 62 of 2021

 

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 5)

 

National Health Act 1953

___________________________________________________________________________

 

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under paragraph 98C(1) of the National Health Act 1953.

Dated         29 June 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NIKOLAI TSYGANOV

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health




___________________________________________________________________________

1          Name of Instrument

(1)          This Instrument is the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 5).

(2)          This Instrument may also be cited as PB 62 of 2021.

2          Commencement

This Instrument commences on 1 July 2021.

3          Amendments to National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019

Schedule 1 amends the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019.

 

 

                     


Schedule 1     Amendments

[1]        Schedule 3, after entry for Hydromorphone in the form Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 200 mL

insert:

Hydromorphone

Oral solution containing hydromorphone hydrochloride 1 mg per mL, 473 mL